AIDS Read. 2002 Dec;12(12):527-35.

Strategies to improve access to sterile syringes for injection drug users.

Source

Brown University School of Medicine, Providence, Rhode Island, USA.

Abstract

The high prevalence of infection with HIV and other blood-borne pathogens in injection drug users (IDUs) is directly related to the lack of syringe access. Needle exchange programs (NEPs), syringe prescription, and syringe deregulation are 3 approaches to increasing access to sterile syringes for IDUs. The benefits of NEPs have been repeatedly demonstrated, but the impact of NEPs has been limited by a lack of federal funding. Syringe prescription for IDUs is a promising new strategy supported by many organizations; legalizing syringe purchase and possession has led to a substantial improvement in syringe access in many states. Because each approach has unique advantages, providing IDUs with a variety of options for syringe access is likely to be most beneficial.

Comment in

AIDS Read. 2002 Dec;12(12):530-1.

PMID:: 12518719; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Other Literature Sources

COS Scholar Universe

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review The role of needle exchange programs in HIV prevention. [Public Health Rep. 1998]
Review The role of needle exchange programs in HIV prevention.
Vlahov D, Junge B. Public Health Rep. 1998 Jun; 113 Suppl 1:75-80.
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. [J Urban Health. 2008]
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC. J Urban Health. 2008 May; 85(3):309-22. Epub 2008 Mar 14.
An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. [J Acquir Immune Defic Syndr Hum Retrovirol....]
An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
Lurie P, Gorsky R, Jones TS, Shomphe L. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S126-32.
Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. [AIDS. 2000]
Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
Taussig JA, Weinstein B, Burris S, Jones TS. AIDS. 2000 Jun; 14 Suppl 1:S47-51.
Review Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. [Int J Drug Policy. 2007]
Review Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA. Int J Drug Policy. 2007 Oct; 18(5):417-25. Epub 2007 Feb 20.

See reviews... See all...

Cited by 3 PubMed Central articles

Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. [J Urban Health. 2010]
Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.
Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. J Urban Health. 2010 Jul; 87(4):534-42.
Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions. [J Urban Health. 2010]
Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.
Rose VJ, Backes G, Martinez A, McFarland W. J Urban Health. 2010 Jul; 87(4):561-75.
A success story: HIV prevention for injection drug users in Rhode Island. [Subst Abuse Treat Prev Policy. 2006]
A success story: HIV prevention for injection drug users in Rhode Island.
Beckwith CG, Moreira CC, Aboshady HM, Zaller N, Rich JD, Flanigan TP. Subst Abuse Treat Prev Policy. 2006 Dec 4; 1:34. Epub 2006 Dec 4.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Strategies to improve access to sterile syringes for injection drug users.
Strategies to improve access to sterile syringes for injection drug users.
AIDS Read. 2002 Dec ;12(12):527-35.

PubMed
Talk about costs: health care professionals' views about expenses related to sub...
Talk about costs: health care professionals' views about expenses related to substance abuse treatment.
Adm Policy Ment Health. 2004 Jul ;31(6):483-94.

PubMed
Alcohol advertising and youth.
Alcohol advertising and youth.
Alcohol Clin Exp Res. 2002 Jun ;26(6):900-6.

PubMed
Substance abuse, treatment needs and access among female sex workers and non-sex...
Substance abuse, treatment needs and access among female sex workers and non-sex workers in Pretoria, South Africa.
Subst Abuse Treat Prev Policy. 2009 May 27 ;4:11.

PubMed
Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
Drug Alcohol Depend. 2007 Apr 17 ;88(1):75-8. Epub 2006 Oct 19 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: